Skip to main content
Equibles

Beneficial ownership — 13D / 13G

85,680 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
TENOR CAPITAL MANAGEMENT Co., L.P. RAAQ Real Asset Acquisition Corp. 13G/A 1.9% 3mo
EVENTIDE ASSET MANAGEMENT, LLC XMTR Xometry, Inc. 13G/A 4% 3mo
NOMURA ASSET MANAGEMENT INTERNATIONAL INC. ONT Onterris, Inc. 13G 6% 3mo
VAN ECK ASSOCIATES CORP AG First Majestic Silver Corp 13G/A 7.2% 3mo
Fourthstone LLC FGFH Foresight Financial Group Inc 13G/A 9.14% 3mo
RA CAPITAL MANAGEMENT, L.P. FULC Fulcrum Therapeutics, Inc. 13G/A 0% 3mo
Vivo Opportunity Fund Holdings, L.P. TENX Tenax Therapeutics, Inc. 13G/A 9% 3mo
LMR Partners LLP GSRV GSR V Acquisition Corp. 13G 8.3% 3mo
Hood River Capital Management LLC NUAI New ERA Energy & Digital, Inc. 13G 8.49% 3mo
Commodore Capital LP IMUX Immunic, Inc. 13G/A 9.9% 3mo
ARMISTICE CAPITAL, LLC TVTX Travere Therapeutics, Inc. 13G/A 1.67% 3mo
1607 Capital Partners, LLC IGI Western Asset Investment Grade Opportunity Trust Inc. 13G/A 5.53% 3mo
CARRONADE CAPITAL MANAGEMENT, LP CTRI Centuri Holdings, Inc. 13G 5.5% 3mo
North Reef Capital Management LP IIIV i3 Verticals, Inc. 13G 5.5% 3mo
Fourthstone LLC MRBK Meridian Corp 13G/A 4.53% 3mo
PRICE T ROWE ASSOCIATES INC /MD/ CGEM Cullinan Therapeutics, Inc. 13G 6.2% 3mo
Whitefort Capital Management, LP OABI OmniAb, Inc. 13G/A 7.1% 3mo
METEORA CAPITAL, LLC IVCB Investcorp Europe Acquisition Corp I Class A Ordinary Shares 13D/A 18.78% 3mo
METEORA CAPITAL, LLC HCMA Hcm III Acquisition Corp. 13G/A 6.62% 3mo
First Trust Capital Management L.P. LEGT Legato Merger Corp. III 13G/A 0% 3mo
BAMCO INC /NY/ ONON On Holding AG 13G 5.65% 3mo
RA CAPITAL MANAGEMENT, L.P. AVTX Avalo Therapeutics, Inc. 13G/A 6.3% 3mo
AWM Investment Company, Inc. VELO Velo3D, Inc. 13G/A 4.1% 3mo
Quantinno Capital Management LP MAN ManpowerGroup Inc. 13G 6.7% 3mo
Andrew Feldman CBRS Cerebras Systems Inc. 13G 9.2% 3mo
Venrock Healthcare Capital Partners III, L.P. ANL Adlai Nortye Group Ltd. 13G/A 4.4% 3mo
ARMISTICE CAPITAL, LLC VYGR Voyager Therapeutics, Inc. 13G/A 5.58% 3mo
BIOTECHNOLOGY VALUE FUND L P IMA ImageneBio, Inc. 13G/A 9.9% 3mo
SUVRETTA CAPITAL MANAGEMENT, LLC KURA Kura Oncology, Inc. 13G/A 9.7% 3mo
Point72 Asset Management, L.P. VNET VNET Group, Inc. 13G/A 6.6% 3mo
Philadelphia Financial Management of San Francisco, LLC CRMN Skyline Builders Group Holding Ltd 13G/A 8.16% 3mo
FULLER & THALER ASSET MANAGEMENT, INC. BBT Beacon Financial Corp 13G/A 4.7% 3mo
T. Rowe Price Investment Management, Inc. PCTY Paylocity Holding Corp 13G/A 5.8% 3mo
ALLIANCEBERNSTEIN L.P. BVFL BV Financial, Inc. 13G/A 8.8% 3mo
G1 Execution Services, LLC PPBT Purple Biotech Ltd. 13G/A 1.4% 3mo
Searchlight Opportunities Fund II GP, LLC DPC DPC Holdings PLC 13G 6% 3mo
Capital Ventures International WOLF Wolfspeed, Inc. 13G/A 6.3% 3mo
PLATINUM EQUITY, LLC INGM Ingram Micro Holding Corp 13G/A 76.9% 3mo
ARISTEIA CAPITAL, L.L.C. CAII Collective Acquisition Corp. II 13G 8.61% 3mo
Vestal Point Capital, LP SLDB Solid Biosciences Inc. 13G/A 4.8% 3mo
ARMISTICE CAPITAL, LLC CALC CalciMedica, Inc. 13G 9.99% 3mo
Harraden Circle Investments, LLC UAC United Acquisition Corp. I 13G/A 9.99% 3mo
PRICE T ROWE ASSOCIATES INC /MD/ VRDN Viridian Therapeutics, Inc.\DE 13G 5.2% 3mo
BIOTECHNOLOGY VALUE FUND L P OKUR OnKure Therapeutics, Inc. 13G/A 8% 3mo
CVI Investments, Inc. SLDP Solid Power, Inc. 13G/A 9.9% 3mo
1607 Capital Partners, LLC EEA European Equity Fund, Inc 13G/A 19.05% 3mo
AMERIPRISE FINANCIAL INC EVG Eaton Vance Short Duration Diversified Income Fund 13G/A 13.6% 3mo
PRICE T ROWE ASSOCIATES INC /MD/ MQ Marqeta, Inc. 13G/A 11.6% 3mo
Cormorant Asset Management, LP MLTX MoonLake Immunotherapeutics 13G/A 4.35% 3mo
EARNEST PARTNERS LLC WWW Wolverine World Wide Inc 13G/A 6.5% 3mo